Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial

NCT01743131 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT01743131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01743131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Lead sponsor
Boston Children's Hospital
Phase
Phase 2
Overall status
Completed
Start date
February 1, 2013
Completion date
March 30, 2024
Enrollment
186 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

graft vs host disease, malignancy